UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 25, 2021
COHERENT, INC.
(Exact name of registrant as specified in its
charter)
Delaware
|
|
001-33962
|
|
94-1622541
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
5100 Patrick Henry Drive
Santa Clara, CA 95054
(Address of principal executive offices)
(408) 764-4000
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol
|
Name of each exchange on which
registered
|
Common Stock, $0.01 par value
|
COHR
|
The NASDAQ Stock Market LLC
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01. Other Events
On March 25, 2021, Coherent,
Inc. (“Coherent”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated by reference herein.
Important Information
and Where You Can Find It
In connection with the
proposed transaction between II-VI Incorporated (“II-VI”) and Coherent (the “Proposed Transaction”), II-VI plans
to file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 that will include
a joint proxy statement of Coherent and II-VI and will constitute a prospectus with respect to shares of II-VI’s common stock to
be issued to Coherent’s stockholders at the completion of the Proposed Transaction (the “Joint Proxy Statement/Prospectus”).
Coherent and II-VI may also file other documents with the SEC regarding the Proposed Transaction. This communication is not a substitute
for the Joint Proxy Statement/Prospectus or any other document which Coherent or II-VI may file with the SEC in connection with the Proposed
Transaction. COHERENT STOCKHOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED
OR WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS,
CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED
MATTERS.
Investors and security
holders will be able to obtain free copies of the Joint Proxy Statement/Prospectus and other relevant documents filed with the SEC by
Coherent and II-VI in connection with the Proposed Transaction through the website maintained by the SEC at www.sec.gov. Additional information
regarding the participants in the solicitation of proxies in respect of the Proposed Transaction, and a description of their direct and
indirect interests, by security holdings or otherwise, will be contained in any registration statement, prospectus, proxy statement and
other relevant materials to be filed with the SEC if and when they become available.
Participants in the
Solicitation of Proxies in Connection with Proposed Transaction
Coherent and its directors
and executive officers may be deemed to be participants in the solicitation of proxies in respect of the Proposed Transaction. Information
regarding Coherent’s directors and executive officers, including a description of their direct and indirect interests in the Proposed
Transaction, by security holdings or otherwise, will be contained in the Joint Proxy Statement/Prospectus. Coherent stockholders may obtain
additional information regarding the direct and indirect interests of the participants in the solicitation of proxies in connection with
the Proposed Transaction, including the direct and indirect interests of Coherent directors and executive officers in the Proposed Transaction,
which may be different than those of Coherent stockholders generally, by reading the Joint Proxy Statement/Prospectus and any other relevant
documents (including any registration statement, prospectus, proxy statement and other relevant materials to be filed with the SEC) that
are filed or will be filed with the SEC relating to the Proposed Transaction. You may obtain free copies of these documents using the
sources indicated above.
No Offer or Solicitation
This document does not
constitute an offer to sell, or the solicitation of an offer to buy, any securities, or a solicitation of any vote or approval, nor shall
there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus
meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Cautionary Note Regarding
Forward-Looking Statements
This document contains
“forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based
on Coherent’s and its board of directors’ current expectations and beliefs and are subject to a number of factors and uncertainties
that could cause actual results to differ materially from those described in these statements.
The following factors, among others, could cause actual results to
differ materially from those described in these forward-looking statements: (i) the completion of the Proposed Transaction on anticipated
terms and timing, including obtaining stockholder and regulatory approvals, anticipated tax treatment, unforeseen liabilities, future
capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future
prospects, business and management strategies for the management, expansion and growth of Coherent’s and II-VI’s businesses
and other conditions to the completion of the transaction; (ii) the occurrence of any event, change or other circumstances that could
give rise to the termination of the merger agreement with II-VI (as amended, restated or supplemented from time to time), including the
receipt of an unsolicited proposal from a third party (including MKS Instruments, Inc. or Lumentum Holdings Inc.); (iii) failure to realize
the anticipated benefits of the Proposed Transaction, including as a result of delay in completing the transaction or integrating the
businesses of Coherent and II-VI; (iv) the impact of the COVID-19 pandemic and related private and public sector measures on Coherent’s
business and general economic conditions; (v) risks associated with the recovery of global and regional economies from the negative effects
of the COVID-19 pandemic and related private and public sector measures; (vi) Coherent’s and II-VI’s ability to implement
its business strategy; (vii) pricing trends, including Coherent’s and II-VI’s ability to achieve economies of scale; (viii)
potential litigation relating to the Proposed Transaction that could be instituted against Coherent, II-VI or their respective directors;
(ix) the risk that disruptions from the Proposed Transaction will harm Coherent’s or II-VI’s business, including current plans
and operations; (x) the ability of Coherent or II-VI to retain and hire key personnel; (xi) potential adverse reactions or changes to
business relationships resulting from the announcement or completion of the Proposed Transaction; (xii) uncertainty as to the long-term
value of II-VI common stock; (xiii) legislative, regulatory and economic developments affecting Coherent’s and II-VI’s businesses;
(xiv) general economic and market developments and conditions; (xv) the evolving legal, regulatory and tax regimes under which Coherent
and II-VI operate; (xvi) potential business uncertainty, including changes to existing business relationships, during the pendency of
the merger that could affect Coherent’s and/or II-VI’s financial performance; (xvii) restrictions during the pendency of the
Proposed Transaction that may impact Coherent’s or II-VI’s ability to pursue certain business opportunities or strategic transactions;
(xviii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities,
as well as Coherent’s and II-VI’s response to any of the aforementioned factors; (xix) geopolitical conditions, including
trade and national security policies and export controls and executive orders relating thereto, and worldwide government economic policies,
including trade relations between the United States and China; (xx) Coherent’s ability to provide a safe working environment for
members during the COVID-19 pandemic or any other public health crises, including pandemics or epidemics; and (xxi) failure to receive
the approval of the stockholders of II-VI and/or Coherent. These risks, as well as other risks associated with the Proposed Transaction,
are more fully discussed in the Joint Proxy Statement/Prospectus to be filed with the SEC in connection with the Proposed Transaction.
While the list of factors presented here is, and the list of factors presented in the Joint Proxy Statement/Prospectus will be, considered
representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. The forward-looking
statements contained herein are made only as of the date hereof, and we undertake no obligation to update or revise the forward-looking
statements, whether as a result of new information, future events or otherwise.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 25, 2021
|
COHERENT, INC.
|
|
|
|
|
By:
|
/s/ Bret DiMarco
|
|
|
Bret DiMarco
|
|
|
Executive Vice President, Chief Legal Officer and Corporate Secretary
|
Coherent (NYSE:COHR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Coherent (NYSE:COHR)
Historical Stock Chart
From Jul 2023 to Jul 2024